RT Journal Article
SR Electronic
T1 COVID-19 booster vaccine attitudes and behaviors among university students and staff: the USC Trojan Pandemic Research Initiative
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.09.21267545
DO 10.1101/2021.12.09.21267545
A1 Lee, Ryan C.
A1 Hu, Howard
A1 Kawaguchi, Eric S.
A1 Kim, Andre. E
A1 Soto, Daniel W.
A1 Shanker, Kush
A1 Klausner, Jeffrey D.
A1 Van Orman, Sarah
A1 Unger, Jennifer B.
YR 2021
UL http://medrxiv.org/content/early/2021/12/11/2021.12.09.21267545.abstract
AB Introduction Although COVID-19 vaccines significantly reduce morbidity and mortality, recent evidence suggests that immunity wanes after 6-9 months, and that a third vaccine dose could further reduce COVID-19 transmission and severe illness. However, previous studies have not assessed attitudes about getting booster doses. This study examined COVID-19 booster vaccine attitudes and behaviors among university students and staff in the fall of 2021.Methods Participants responded to an email invitation and completed electronic surveys. Results. In our sample, 96.2% of respondents indicated willingness to get a COVID-19 booster shot at least once per year. In both bivariate and multivariate analyses higher trust in science was associated with having higher odds of booster willingness. Those who identify as Black, on average, reported trusting science less than other racial/ethnic groups.Conclusions Our findings demonstrate high willingness to receive a COVID-19 booster shot and highlight the importance of educational and motivational messages that focus on trust in science to increase willingness to get the COVID-19 booster. More research is needed to better understand the impact of cultural beliefs on booster willingness and vaccine hesitancy. This understanding will help determine what messages and populations to target to increase booster willingness in the future.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research has been funded by the University of Southern California Office of the Provost and the Keck Medicine Foundation. E. Kawaguchi is funded by the NIH T32ES013678. A. Kim is funded by the USC Environmental Health Biostatistics Core (P30 ES007048)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Southern California IRBI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors